Differences in Coagulation Test Kits

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-31

Study Completion Date

2010-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess the effect of Innovin® reagent on laboratory results when compared with the Thromborel® S.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers

NCT03666650

Blood Coagulation Disorder

COMPLETED PHASE4

Enoxaparin in Acute Venous Thromboembolic Disease

NCT00265993

Venous Thrombosis

COMPLETED PHASE4

Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care

NCT03154489

Anticoagulant Pharmacogenetics Community Pharmacy Services +2 more

COMPLETED NA

Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus

NCT05006677

Ventricular Thrombus

UNKNOWN

A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"

NCT00334464

Atrial Fibrillation Deep Vein Thrombosis Pulmonary Embolism

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Thromboplastins are the screening tests which are used in the diagnosis of acquired or inherited disorders of the coagulation system but still, alterations between various thromboplastin preparations in the measurements remains a problem.Blood samples are going to drawn from patients receiving and not receiving oral anticoagulant therapy (OAT) during their routine laboratory tests. Samples are subjected to analysis by using Thromborel® S and Innovin® reagents. Mean International Normalized Ratio (INR), prothrombin time and fibrinogen values are going to compared. To further study the importance of this phenomenon the cohort will be divided into three subgroups according to the INR values as Group I: Patients not receiving OAT, Group II: Patients under OAT and INR values in good therapeutic range and Group III: Patients under OAT and INR values over the therapeutic range.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Effect of Different Reagents. Oral Anticoagulant Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

oral anticoagulant

Patients receiving and not receiving oral anticoagulant therapy.

No interventions assigned to this group

INR Level

Group I: Patients not receiving OAT, Group II: Patients under OAT and INR values in good therapeutic range and Group III: Patients under OAT and INR values over the therapeutic range.

No interventions assigned to this group